Tesamorelin 10mg
(GHRH)

Premium Grade | UK Supply

(Tetradecapeptide–14 Amino Acids)

Brief Summery

Tesamorelin is a peptide analogue studied in laboratory settings for its interaction with growth hormone releasing hormone pathways and related endocrine signalling research. It is commonly examined in controlled investigational models focused on pituitary response patterns, hormone cascade activity, and peptide receptor mediated mechanisms. Within scientific supply catalogues, Tesamorelin is valued for structured in vitro and preclinical research involving signalling regulation, secretion dynamics, and comparative peptide analysis. Its role in research centres on pathway observation, biochemical marker evaluation, and documented laboratory handling, making it suitable for professional scientific environments requiring clear presentation and consistent research focused supply standards.

Product Overview

Tesamorelin is a synthetic peptide analogue of growth hormone releasing hormone (GHRH), specifically engineered to stimulate natural production and pulsatile release of endogenous growth hormone (GH). Unlike direct growth hormone administration, Tesamorelin acts upstream at the hypothalamic pituitary axis, promoting physiological GH secretion while maintaining the intrinsic regulatory feedback mechanisms. In research settings, Tesamorelin is widely studied for its role in influencing metabolic regulation, lipid metabolism, composition, and endocrine signalling. Due to its high specificity for the GHRH receptor, Tesamorelin offers a targeted approach for investigating growth hormone mediated pathways without permanently suppressing or overriding natural hormone production. Tesamorelin has become an important compound in peptide research due to its stability, selectivity, and predictable biological activity, making it a valuable tool for studies exploring growth hormone dynamics, metabolic health, and age-related endocrine changes.

Scientific Background

Tesamorelin is a stabilized, modified version of endogenous growth hormone releasing hormone, consisting of 44 amino acids with structural alterations that enhance resistance to enzymatic degradation. These modifications significantly extend its half life compared to native GHRH, allowing for sustained receptor activation and consistent biological responses in controlled research environments. At the molecular level, Tesamorelin binds to GHRH receptors located on somatotroph cells in the anterior pituitary gland. This binding initiates a signalling cascade involving cyclic AMP (cAMP) and protein kinase A (PKA), ultimately stimulating the synthesis and pulsatile release of growth hormone. The resulting increase in GH subsequently elevates circulating insulin-like growth factor-1 (IGF-1), a key mediator of many anabolic, metabolic, and regenerative processes. Importantly, Tesamorelin preserves normal negative feedback regulation via somatostatin and IGF-1 pathways. This characteristic differentiates it from exogenous GH and makes it especially valuable for research examining physiological hormone rhythms, endocrine resilience, and long-term hormonal adaptation rather than forced hormone replacement.

Research Applications

Tesamorelin is extensively researched in the context of metabolic science, endocrinology, and age related physiological changes. One of its primary research applications involves the investigation of visceral adipose tissue regulation and lipid metabolism, as growth hormone plays a central role in lipolysis and fat distribution. In endocrine research, Tesamorelin is used to study growth hormone deficiency models, hypothalamic pituitary axis function, and GH-IGF-1 signalling integrity. Researchers also explore its effects on glucose metabolism, insulin sensitivity, and energy homeostasis, making it relevant in studies focused on metabolic disorders and body composition dynamics. Additionally, Tesamorelin is investigated for its potential influence on cellular repair mechanisms, protein synthesis, and tissue maintenance through downstream IGF-1 activity. Its ability to stimulate endogenous hormone release while maintaining physiological control systems makes it a valuable compound for long term studies assessing hormonal modulation, aging processes, and endocrine system adaptability.

Technical Specifications

• Contents: 10mg Tesamorelin
• Form: Lyophilized powder
• Purity: >99% (HPLC Verified)
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
• Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gly-Gln-Glu-Ser-Asn-Ile-Asp-Leu-Arg-Gln-Gln-Gly-Gly-Gly-Gly-Ser-Arg-Arg-Ile-Leu-Phe-Thr-Gln-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp
• Peptide Length: 44 Amino-Acids
• pH Range: 4.5-7.5
• Storage: Store between 2°C and 8°C

Note: Reconstitute with 50% Bacteriostatic (BAC) water and 50% Acetic Acid for best results.

Related Research Compounds

Hexarelin 5mg
CJC-1295 10mg
Sermorelin 10mg

Disclaimer

For research purposes only, Not for human consumption.